Science Explorer Back to mapMap
Discussion
Company · Lake Oswego · United States

PDX Pharmaceuticals (United States)

pdxpharm.comROR OpenAlex
Research works
26
◆ 2% vs 2018-21
Citations
1.2k
45.7 per fractional work
Top-10% rate
15.5%
all institutions 10.0%
Open access
61%
world 40%
International
17%
world 18%
PDX Pharmaceuticals (United States)

Not ranked overall: PDX Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does PDX Pharmaceuticals (United States) work in?

In all years, 40% of research at PDX Pharmaceuticals (United States) is in Life Sciences, 28% in Health Sciences. Its largest fields are Medicine (26%), Biochemistry, Genetics and Molecular Biology (23%), Engineering (13%). It does 1.9× the world's share of Life Sciences.

Life Sciences: 10 fractional works · 40.3% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 22.6% of its workMolecular Biology: 5 fractional works · 17.9% of its workCancer Research: 0 fractional works · 1.2% of its workBiotechnology: 0 fractional works · 1.1% of its workGenetics: 0 fractional works · 0.7% of its workBiochemistry: 0 fractional works · 0.7% of its workBiophysics: 0 fractional works · 0.7% of its workDevelopmental Biology: 0 fractional works · 0.4% of its workImmunology and Microbiology: 2 fractional works · 7.6% of its workImmunology: 2 fractional works · 7.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 4.8% of its workPharmaceutical Science: 1 fractional works · 3.2% of its workToxicology: 0 fractional works · 1.3% of its workPharmacology: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 1 fractional works · 2.7% of its workEcology, Evolution, Behavior and Systematics: 1 fractional works · 2.7% of its workNeuroscience: 1 fractional works · 2.6% of its workCognitive Neuroscience: 0 fractional works · 1.3% of its workSensory Systems: 0 fractional works · 0.7% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workHealth Sciences: 7 fractional works · 27.6% of its workMedicine: 7 fractional works · 26.2% of its workOncology: 3 fractional works · 10.4% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.7% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.6% of its workSurgery: 0 fractional works · 1.9% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.3% of its workImmunology and Allergy: 0 fractional works · 1.3% of its workPharmacology: 0 fractional works · 1.3% of its workPhysiology: 0 fractional works · 1.3% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.1% of its workEpidemiology: 0 fractional works · 0.7% of its workPathology and Forensic Medicine: 0 fractional works · 0.7% of its workHematology: 0 fractional works · 0.4% of its workInfectious Diseases: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 1.1% of its workNutrition and Dietetics: 0 fractional works · 1.1% of its workVeterinary: 0 fractional works · 0.3% of its workSmall Animals: 0 fractional works · 0.3% of its workPhysical Sciences: 7 fractional works · 25.6% of its workEngineering: 3 fractional works · 12.5% of its workBiomedical Engineering: 2 fractional works · 7.5% of its workMechanical Engineering: 0 fractional works · 1.7% of its workOcean Engineering: 0 fractional works · 1.7% of its workMechanics of Materials: 0 fractional works · 1.3% of its workComputational Mechanics: 0 fractional works · 0.3% of its workEnvironmental Science: 2 fractional works · 6.0% of its workEcology: 0 fractional works · 1.9% of its workNature and Landscape Conservation: 0 fractional works · 1.2% of its workGlobal and Planetary Change: 0 fractional works · 1.0% of its workEcological Modeling: 0 fractional works · 0.8% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.7% of its workPollution: 0 fractional works · 0.4% of its workMaterials Science: 2 fractional works · 5.9% of its workBiomaterials: 1 fractional works · 4.6% of its workMaterials Chemistry: 0 fractional works · 0.7% of its workPolymers and Plastics: 0 fractional works · 0.7% of its workChemistry: 0 fractional works · 0.7% of its workOrganic Chemistry: 0 fractional works · 0.4% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.4% of its workGeophysics: 0 fractional works · 0.4% of its workSocial Sciences: 2 fractional works · 6.4% of its workPsychology: 1 fractional works · 2.6% of its workClinical Psychology: 1 fractional works · 2.6% of its workArts and Humanities: 0 fractional works · 1.3% of its workHistory and Philosophy of Science: 0 fractional works · 1.3% of its workBusiness, Management and Accounting: 0 fractional works · 1.3% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 1.3% of its workSocial Sciences: 0 fractional works · 1.3% of its workPolitical Science and International Relations: 0 fractional works · 1.3% of its workALL ITS WORKPDXPharmaceuticals…26fractional works, all years
Life Sciences40%Physical Sciences26%Health Sciences28%Social Sciences6%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology622.6%
    2. Immunology and Microbiology27.6%
    3. Pharmacology, Toxicology and Pharmaceutics14.8%
    4. Agricultural and Biological Sciences12.7%
    5. Neuroscience12.6%
    1. Medicine726.2%
    2. Nursing01.1%
    3. Veterinary00.3%
    1. Engineering312.5%
    2. Environmental Science26.0%
    3. Materials Science25.9%
    4. Chemistry00.7%
    5. Earth and Planetary Sciences00.4%
    1. Psychology12.6%
    2. Arts and Humanities01.3%
    3. Business, Management and Accounting01.3%
    4. Social Sciences01.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.19× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.39× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 12.08× its world share, 1 worksImmunology and Micro…Neuroscience: 1.64× its world share, 0 worksNeuroscienceChemistry: 1.03× its world share, 0 worksChemistryEngineering: 1.08× its world share, 1 worksEngineeringEnvironmental Science: 0.98× its world share, 0 worksEnvironmental ScienceMaterials Science: 1.16× its world share, 0 worksMaterials ScienceMedicine: 1.24× its world share, 2 worksMedicineNursing: 3.31× its world share, 0 worksNursingArts and Humanities: 1.68× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 1.51× its world share, 0 worksBusiness, Management…Social Sciences: 0.38× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.1×. Every wedge is a field page.

All 13 fields, with their numbers
  1. Immunology and Microbiology12.08×1 works
  2. Nursing3.31×0 works
  3. Biochemistry, Genetics and Molecular Biology2.39×1 works
  4. Arts and Humanities1.68×0 works
  5. Neuroscience1.64×0 works
  6. Business, Management and Accounting1.51×0 works
  7. Medicine1.24×2 works
  8. Agricultural and Biological Sciences1.19×0 works
  9. Materials Science1.16×0 works
  10. Engineering1.08×1 works
  11. Chemistry1.03×0 works
  12. Environmental Science0.98×0 works
  13. Social Sciences0.38×0 works

Who are the top researchers at PDX Pharmaceuticals (United States)?

Ranked on the quality score, Moataz M. Reda lead among researchers whose main affiliation is PDX Pharmaceuticals (United States).

  1. 1 Moataz M. Reda United States · #1,072,080 worldwide 975 citations · 37 works
All ranked researchers at PDX Pharmaceuticals (United States)

What are the most cited papers from PDX Pharmaceuticals (United States)?

The most cited paper from PDX Pharmaceuticals (United States) is "Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles" (Jingga Morry, Worapol Ngamcherdtrakul, Wassana Yantasee, 2016), with 335 citations. Next come "Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment" (197) and "Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2+ Breast Cancer" (193).

Most cited papers
#PaperReleasedCitations
1 Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles Jingga Morry, Worapol Ngamcherdtrakul, Wassana Yantasee · Redox Biology Open access 16 Dec 2016 335
2 Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment Moataz M. Reda, Worapol Ngamcherdtrakul, Molly A. Nelson et al. · Nature Communications Open access 23 Jul 2022 197
3 Cationic Polymer Modified Mesoporous Silica Nanoparticles for Targeted siRNA Delivery to HER2+ Breast Cancer Worapol Ngamcherdtrakul, Jingga Morry, Shenda Gu et al. · Advanced Functional Materials Open access 24 Mar 2015 193
4 Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer Molly A. Nelson, Worapol Ngamcherdtrakul, Shiuh‐Wen Luoh et al. · Cancer and Metastasis Reviews ReviewOpen access 7 May 2021 126
5 Free mate choice enhances conservation breeding in the endangered giant panda Meghan S. Martin‐Wintle, David J. Shepherdson, Guiquan Zhang et al. · Nature Communications Open access 15 Dec 2015 120
All 44 most cited papers, with filters and sorting

Which keywords describe research at PDX Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Nanoparticles, Tumor Targeting, Immunotherapy, Drug Delivery, Cancer Therapy, Biomedical Applications, Gene Therapy and Reactive Oxygen Species.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 27 words, with their numbers
  1. Nanoparticles5▲ 13×8 topics
  2. Tumor Targeting3▲ 79×3 topics
  3. Immunotherapy2▲ 14×6 topics
  4. Drug Delivery2▲ 17×6 topics
  5. Cancer Therapy2▲ 12×6 topics
  6. Biomedical Applications2▲ 6.5×4 topics
  7. Gene Therapy2▲ 23×2 topics
  8. Reactive Oxygen Species2▲ 12×3 topics
  9. Immunity2▲ 17×5 topics
  10. Tumor Microenvironment2▲ 16×4 topics
  11. Biosensors1▲ 9.4×2 topics
  12. Climate Change1▲ 2.1×8 topics
  13. Inflammation1▲ 2.3×8 topics
  14. Photodynamic Therapy1▲ 34×2 topics
  15. RNA Interference1▲ 44×1 topic
  16. siRNA Delivery1▲ 66×1 topic
  17. Biomolecular Interactions1▲ 38×2 topics
  18. Fluorescence Imaging1▲ 42×1 topic
  19. Immune Checkpoint Blockade1▲ 81×1 topic
  20. Innate Immunity1▲ 13×4 topics
  21. Nanocarriers1▲ 107×1 topic
  22. PD-1 and PD-L11▲ 81×1 topic
  23. Photothermal Therapy1▲ 56×1 topic
  24. Surface Engineering1▲ 41×1 topic
  25. DNA nanotechnology1▲ 42×1 topic
  26. Self-Assembly1▲ 11×1 topic
  27. Cancer Immunotherapy1▲ 28×2 topics

Which research topics does PDX Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Nanoplatforms for cancer theranostics, Cancer Immunotherapy and Biomarkers, Nanoparticle-Based Drug Delivery and Animal Behavior and Reproduction.

Nanoplatforms for cancer…1Nanoplatforms for cancer theranostics: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksNanoparticle-Based Drug Delivery: 0 fractional worksAnimal Behavior and Reproduction: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksLung Cancer Research Studies: 0 fractional worksPublishing and Scholarly Communication: 0 fractional worksOrganizational Learning and Leadership: 0 fractional worksPolitical Developments and Conflicts: 0 fractional worksReceptor Mechanisms and Signaling: 0 fractional works
Biomedical EngineeringOncologyBiomaterialsEcology, Evolution, Behavior and Systematics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Nanoplatforms for cancer theranostics Biomedical Engineering 1 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
  3. 3 Nanoparticle-Based Drug Delivery Biomaterials 0 works
  4. 4 Animal Behavior and Reproduction Ecology, Evolution, Behavior and Systematics 0 works
  5. 5 Immunotherapy and Immune Responses Immunology 0 works
  6. 6 Lung Cancer Research Studies Oncology 0 works
  7. 7 Publishing and Scholarly Communication History and Philosophy of Science 0 works
  8. 8 Organizational Learning and Leadership Organizational Behavior and Human Resource Management 0 works
  9. 9 Political Developments and Conflicts Political Science and International Relations 0 works
  10. 10 Receptor Mechanisms and Signaling Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available61.4%not open38.6%

World: 40% of research is openly available.

with international co-authors16.9%domestic only83.1%

World: 18% is written across borders.

How has PDX Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 2% higher than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is PDX Pharmaceuticals (United States) as a percentage of every work published that year, 0.000027% in 2024.

still counting0.000050%0.00010%0.00015%PDX Pharmaceuticals (United States)0.000023% in 2025200020102020

Fractional works of PDX Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lake Oswego

All research institutions in Lake Oswego

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about PDX Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.